Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Three-Minute rule for safer intubation in obese women?

NCT ID NCT04808440

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 36 times

Summary

This study looked at how well a muscle relaxant called atracurium works for placing a breathing tube in 100 obese women undergoing gynecological surgery. Doctors waited exactly three minutes after giving the drug before attempting intubation. The goal was to see if this timing leads to good or excellent intubation conditions. The study is complete and helps guide anesthesia care for this specific group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY FEMALE PATIENTS REQUIRE GENERAL ANAESTHESIA WITH INTUBATION AND ATRACURIUM CURARIZATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Service Anesthésie Réanimation Chirurgicale Hôpital Cochin

    Paris, 75014, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

atracurium

What this could lead to

If successful, this could help anesthesiologists choose better timing for muscle relaxants during intubation in obese women.

What could go wrong

This is a small, completed study in a specific group (obese women). Results may not apply to other patients or settings, and the study does not test long-term outcomes.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.